a

adMare BioInnovations

155 employees

adMare Bio innovations is a global life sciences venture, building Canadian life sciences from sea to sea.

Investor insights

Sectors invested in

Biotechnology7

Pharmaceutical4

Health Care3

Biopharma2

Medical2

Therapeutics2

Life Science1

Funding rounds participated in

$38M sweet spot round size

Most of their 7 investments are in rounds between $25M and $41M

Investor type

Accelerator

Venture Capital

Basic info

Industry

biotechnology research

Sectors

drug development

pharmaceuticals

technology

rechereche

health

research

biotechnology

sante

healthcare

biologie

medicine

drug discovery

oncology

womeninscience

life sciences

startups

oncologie

biotech

Date founded

2019

Investments made

I

Inversago Pharma Inc raised $69M on October 17, 2022

Investors: Forbion, Genesys Capital, JDRF T1D Fund and adMare BioInnovations

I

Immugenia Inc. raised undisclosed on October 6, 2022

Investors: ACET Banque Nationale, Sherbrooke Innopole and adMare BioInnovations

D

Domain Therapeutics raised $41M on May 10, 2022

Investors: Schroders Capital, 3B Future Health Fund, Theodorus Investment Funds, Omnes, Viva BioInnovator, Seventure Partners and adMare BioInnovations

S

Specific Biologics raised undisclosed on December 16, 2021

Investors: Lumira Ventures and adMare BioInnovations

I

Inversago Pharma Inc raised $35M on September 8, 2020

Investors: AQC Capital, Genesys Capital, JDRF T1D Fund, Forbion and adMare BioInnovations

B

Bright Angel Therapeutics raised undisclosed on December 3, 2019

Investors: MaRS Investment Accelerator Fund, Viva BioInnovator, Lumira Ventures and adMare BioInnovations

-

- raised $25M on July 8, 2019

Investors: Desjardins Entreprises - Capital régional et coopératif and adMare BioInnovations